Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker ANNX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Thomas G. Wiggans Former Director | ANNX Annexon, Inc. | 2,000 | $10.6K | — | Aug 13, 2026 | — | Form 144 ↗ |
| Jul 15, 2026 | Thomas G. Wiggans Former Director | ANNX Annexon, Inc. | 2,000 | $12.6K | — | Jul 15, 2026 | — | Form 144 ↗ |
| Jul 14, 2026 | Thomas G. Wiggans Former Director | ANNX Annexon, Inc. | 1,000 | $5,605 | — | Jul 14, 2026 | — | Form 144 ↗ |
| Mar 2, 2026 | Ted Yednock Officer | ANNX Annexon, Inc. | 5,566 | $30.2K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 5,566 shares | Form 144 ↗ |
| Mar 2, 2026 | Dean Richard Artis Officer | ANNX Annexon, Inc. | 5,894 | $32.0K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 5,894 shares | Form 144 ↗ |
| Mar 2, 2026 | Michael Overdorf Officer | ANNX Annexon, Inc. | 4,339 | $23.5K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 4,339 shares | Form 144 ↗ |
| Mar 2, 2026 | Jamie Dananberg Officer | ANNX Annexon, Inc. | 5,820 | $31.6K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 5,820 shares | Form 144 ↗ |
| Mar 2, 2026 | Jennifer Lew Officer | ANNX Annexon, Inc. | 5,565 | $30.2K | — | Mar 2, 2026 | Form 4 ↗ 2 days later · 5,565 shares | Form 144 ↗ |
| Feb 18, 2026 | Jennifer Lew Officer | ANNX Annexon, Inc. | 7,851 | $40.1K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 7,851 shares | Form 144 ↗ |
| Feb 18, 2026 | Dean Richard Artis Officer | ANNX Annexon, Inc. | 5,290 | $27.0K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 5,290 shares | Form 144 ↗ |
| Feb 18, 2026 | Ted Yednock Officer | ANNX Annexon, Inc. | 7,857 | $40.1K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 7,857 shares | Form 144 ↗ |
| Feb 18, 2026 | Michael Overdorf Officer | ANNX Annexon, Inc. | 6,225 | $31.8K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 6,225 shares | Form 144 ↗ |
| Feb 18, 2026 | Jamie Dananberg Officer | ANNX Annexon, Inc. | 5,290 | $27.0K | — | Feb 18, 2026 | Form 4 ↗ 2 days later · 5,290 shares | Form 144 ↗ |
| Jul 14, 2025 | Ted Yednock Officer | ANNX Annexon, Inc. | 1,116 | $2,881 | — | Jul 14, 2025 | Form 4 ↗ 2 days later · 1,116 shares | Form 144 ↗ |
| Jul 14, 2025 | Michael Overdorf Officer | ANNX Annexon, Inc. | 853 | $2,226 | — | Jul 14, 2025 | Form 4 ↗ 2 days later · 853 shares | Form 144 ↗ |
| Jul 14, 2025 | Jennifer Lew Officer | ANNX Annexon, Inc. | 1,117 | $2,881 | — | Jul 14, 2025 | Form 4 ↗ 2 days later · 1,117 shares | Form 144 ↗ |
| Feb 18, 2025 | Ted Yednock Officer | ANNX Annexon, Inc. | 8,345 | $24.3K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 8,345 shares | Form 144 ↗ |
| Feb 18, 2025 | Jennifer Lew Officer | ANNX Annexon, Inc. | 8,338 | $24.3K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 6,912 shares | Form 144 ↗ |
| Feb 18, 2025 | Dean Richard Artis Officer | ANNX Annexon, Inc. | 5,515 | $16.4K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 5,515 shares | Form 144 ↗ |
| Feb 18, 2025 | Jamie Dananberg Officer | ANNX Annexon, Inc. | 5,521 | $16.4K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 5,521 shares | Form 144 ↗ |
| Feb 18, 2025 | Michael Overdorf Officer | ANNX Annexon, Inc. | 6,618 | $19.5K | — | Feb 18, 2025 | Form 4 ↗ 2 days later · 6,618 shares | Form 144 ↗ |
| Feb 13, 2025 | Ted Yednock Officer | ANNX Annexon, Inc. | 1,783 | $5,316 | — | Feb 13, 2025 | Form 4 ↗ 5 days later · 1,783 shares | Form 144 ↗ |
| Feb 13, 2025 | Douglas Love Officer, Director | ANNX Annexon, Inc. | 5,021 | $14.8K | — | Feb 13, 2025 | Form 4 ↗ 5 days later · 5,021 shares | Form 144 ↗ |
| Feb 13, 2025 | Jennifer Lew Officer | ANNX Annexon, Inc. | 1,786 | $5,314 | — | Feb 13, 2025 | Form 4 ↗ 5 days later · 1,786 shares | Form 144 ↗ |
| Feb 13, 2025 | Michael Overdorf Officer | ANNX Annexon, Inc. | 1,425 | $4,265 | — | Feb 13, 2025 | Form 4 ↗ 5 days later · 1,425 shares | Form 144 ↗ |
| Oct 15, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 5,408 | $40.1K | 10b5-1 | Oct 15, 2024 | Form 4 ↗ 2 days later · 5,408 shares | Form 144 ↗ |
| Sep 19, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 4,500 | $31.9K | 10b5-1 | Sep 19, 2024 | Form 4 ↗ 28 days later · 5,408 shares | Form 144 ↗ |
| Sep 12, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 5,500 | $33.9K | 10b5-1 | Sep 12, 2024 | Form 4 ↗ 35 days later · 5,408 shares | Form 144 ↗ |
| Sep 5, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 5,500 | $31.0K | 10b5-1 | Sep 5, 2024 | Form 4 ↗ 42 days later · 5,408 shares | Form 144 ↗ |
| Aug 29, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 5,500 | $32.7K | 10b5-1 | Aug 29, 2024 | Form 4 ↗ 49 days later · 5,408 shares | Form 144 ↗ |
| Jul 15, 2024 | Michael Overdorf Officer | ANNX Annexon, Inc. | 784 | $4,720 | — | Jul 15, 2024 | — | Form 144 ↗ |
| Jul 15, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 1,106 | $6,656 | — | Jul 15, 2024 | — | Form 144 ↗ |
| Jul 15, 2024 | Jennifer Lew Officer | ANNX Annexon, Inc. | 1,104 | $6,656 | — | Jul 15, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 2,604 | $14.3K | — | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Jennifer Lew Officer | ANNX Annexon, Inc. | 2,593 | $14.3K | — | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 20, 2024 | Michael Overdorf Officer | ANNX Annexon, Inc. | 1,951 | $10.7K | — | Feb 20, 2024 | — | Form 144 ↗ |
| Feb 12, 2024 | Michael Overdorf Officer | ANNX Annexon, Inc. | 1,349 | $7,458 | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 12, 2024 | Douglas Love Officer, Director | ANNX Annexon, Inc. | 5,782 | $32.1K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 12, 2024 | Jennifer Lew Officer | ANNX Annexon, Inc. | 1,809 | $10.0K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Feb 12, 2024 | Ted Yednock Officer | ANNX Annexon, Inc. | 1,810 | $10.0K | — | Feb 12, 2024 | — | Form 144 ↗ |
| Dec 27, 2023 | Ted Yednock Officer | ANNX Annexon, Inc. | 21,000 | $94.5K | 10b5-1 | Dec 27, 2023 | — | Form 144 ↗ |
| Jul 13, 2023 | Jennifer Lew Officer | ANNX Annexon, Inc. | 1,057 | $4,055 | — | Jul 13, 2023 | — | Form 144 ↗ |
| Jul 13, 2023 | Ted Yednock Officer | ANNX Annexon, Inc. | 1,057 | $4,055 | — | Jul 13, 2023 | — | Form 144 ↗ |
| Jul 13, 2023 | Michael Overdorf Officer | ANNX Annexon, Inc. | 978 | $3,752 | — | Jul 13, 2023 | — | Form 144 ↗ |
44 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 6:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances